Ahmanson-Lovelace Brain Mapping Center, University of California, Los Angeles, Los Angeles, CA 90095-7085, USA.
Neuron. 2012 Sep 6;75(5):904-15. doi: 10.1016/j.neuron.2012.07.010.
As genes that confer increased risk for autism spectrum disorder (ASD) are identified, a crucial next step is to determine how these risk factors impact brain structure and function and contribute to disorder heterogeneity. With three converging lines of evidence, we show that a common, functional ASD risk variant in the Met Receptor Tyrosine Kinase (MET) gene is a potent modulator of key social brain circuitry in children and adolescents with and without ASD. MET risk genotype predicted atypical fMRI activation and deactivation patterns to social stimuli (i.e., emotional faces), as well as reduced functional and structural connectivity in temporo-parietal regions known to have high MET expression, particularly within the default mode network. Notably, these effects were more pronounced in individuals with ASD. These findings highlight how genetic stratification may reduce heterogeneity and help elucidate the biological basis of complex neuropsychiatric disorders such as ASD.
随着自闭症谱系障碍(ASD)风险增加的基因被鉴定出来,下一步的关键是确定这些风险因素如何影响大脑结构和功能,并导致疾病异质性。我们通过三条证据线索表明,MET 受体酪氨酸激酶(MET)基因中的一个常见的、功能性 ASD 风险变异是儿童和青少年中与 ASD 相关和不相关的关键社会大脑回路的强有力调节剂。MET 风险基因型预测了对社会刺激(即情绪面孔)的 fMRI 激活和去激活模式的异常,以及在具有高 MET 表达的颞顶区域中的功能和结构连接减少,尤其是在默认模式网络中。值得注意的是,这些影响在 ASD 个体中更为明显。这些发现强调了遗传分层如何减少异质性,并有助于阐明自闭症等复杂神经精神疾病的生物学基础。